SCHEMBL8618296

SCHEMBL8618296

NC(CCCO)C(=O)O.c1ccc2c(c1)C2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.48
LTA4H P09960 2/20 0.48
POLB P06746 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
KIF11 P52732 3/20 0.46
GSR P00390 2/20 0.46
SLC1A3 P43003 2/20 0.46
SLC1A2 P43004 2/20 0.46
SLC1A1 P43005 2/20 0.46
GRIK1 P39086 2/20 0.46
GRM2 Q14416 2/20 0.46
GRM3 Q14832 2/20 0.46
GRM8 O00222 1/20 0.46
GRM6 O15303 1/20 0.46
GRIN2D O15399 1/20 0.46
GRIN3B O60391 1/20 0.46
CYP1A2 P05177 1/20 0.46
GRM5 P41594 1/20 0.46
GRIA1 P42261 1/20 0.46
GRIA2 P42262 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8618080 0.95 POLB (0.50) KMT2ALTA4HPOLBTDP1KIF11
Homoserine SCHEMBL6051437 0.90 KIF11 (0.49) KMT2ALTA4HPOLBTDP1KIF11
D-Glutamate SCHEMBL561574 0.86 SLC1A3 (0.64) KMT2ALTA4HPOLBTDP1KIF11
Glutamine SCHEMBL4989095 0.85 KMT2A (0.66) KMT2ALTA4HPOLBTDP1KIF11
Glutamine SCHEMBL8630970 0.83 KMT2A (0.63) KMT2ALTA4HPOLBTDP1KIF11
Serine SCHEMBL7658418 0.82 ALPI (0.50) LTA4HKIF11SLC1A3SLC1A2SLC1A1
Serine SCHEMBL561331 0.82 ALPI (0.50) LTA4HKIF11SLC1A3SLC1A2SLC1A1
(D)-Serine SCHEMBL6794292 0.82 ALPI (0.50) LTA4HKIF11SLC1A3SLC1A2SLC1A1
SCHEMBL59755 0.80
SCHEMBL31036022 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5710324-A AMINE CONTAINING COMPOUNDS MERRELL PHARMACEUTICALS INC. (US) 1998-01-20 US disclosed
US-5318992-A Administering for the treatment of hypotensive conditions and shock MERRELL DOW PHARMACEUTICALS INC. (US) 1994-06-07 US disclosed
EP-0446699-A1 Inhibitors of nitric oxide biosynthesis MERRELL PHARMACEUTICALS INC. (US) 1991-09-18 EP disclosed